secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001193125-25-258662
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences CFO Scott Ullem to step down by mid-2026; successor search underway
--------------------------------------------------------------------------------

- CFO Scott Ullem informed company on Oct. 30, 2025 of decision to transition by mid-2026.
- Company initiating selection process to appoint a new CFO; Ullem will serve in advisory role after appointment.
- Plan described as a planned transition to ensure continuity and smooth handoff.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312525258662/0001193125-25-258662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312525258662/d50813d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-258662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer